...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New trial

"That timeline seems to line up with the conclusion of these ongoing trials."

Surely,... not by design!!

 

Koo

Share
New Message
Please login to post a reply